Osamu Nureki
Founder presso MODALIS THERAPEUTICS CORPORATION
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Osamu Nureki is the founder of Modalis Therapeutics Corp., which was founded in 2016.
He holds the title of Outside Director at the company.
He is also currently working as an Outside Director at Curreio, Inc. since 2019.
Additionally, he has been a Professor at the University of Tokyo since 2008.
Dr. Nureki completed his undergraduate and graduate degrees at the University of Tokyo.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2023 | 2 266 100 ( 6.70% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Osamu Nureki
| Società | Posizione | Inizio |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Founder | 01/01/2016 |
Curreio, Inc.
 Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai. | Director/Board Member | 01/11/2019 |
| University of Tokyo | Corporate Officer/Principal | 01/04/2008 |
Formazione di Osamu Nureki
| University of Tokyo | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MODALIS THERAPEUTICS CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Curreio, Inc.
Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai. | Health Technology |
- Borsa valori
- Insiders
- Osamu Nureki
